243 related articles for article (PubMed ID: 25204672)
1. MicroRNAs as a novel class of diagnostic biomarkers in detection of hepatocellular carcinoma: a meta-analysis.
Yin H; Peng X; Ren P; Cheng B; Li S; Qin C
Tumour Biol; 2014 Dec; 35(12):12317-26. PubMed ID: 25204672
[TBL] [Abstract][Full Text] [Related]
2. The Diagnostic Value of MicroRNAs as a Biomarker for Hepatocellular Carcinoma: A Meta-Analysis.
Jiang Y; He J; Li Y; Guo Y; Tao H
Biomed Res Int; 2019; 2019():5179048. PubMed ID: 31871941
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review and Meta-Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma.
Huang JT; Liu SM; Ma H; Yang Y; Zhang X; Sun H; Zhang X; Xu J; Wang J
J Cell Physiol; 2016 Feb; 231(2):328-35. PubMed ID: 26291451
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of circulating microRNAs for hepatocellular carcinoma.
Yang Y; Zhu R
Mol Biol Rep; 2014 Oct; 41(10):6919-29. PubMed ID: 25030834
[TBL] [Abstract][Full Text] [Related]
5. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis.
Li G; Shen Q; Li C; Li D; Chen J; He M
Clin Transl Oncol; 2015 Sep; 17(9):684-93. PubMed ID: 25956842
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
Jiang L; Cheng Q; Zhang BH; Zhang MZ
Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology.
Sartorius K; Sartorius B; Kramvis A; Singh E; Turchinovich A; Burwinkel B; Madiba T; Winkler CA
BMC Cancer; 2017 Dec; 17(1):894. PubMed ID: 29282036
[TBL] [Abstract][Full Text] [Related]
9. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
[TBL] [Abstract][Full Text] [Related]
10. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC).
Shehab-Eldeen S; Nada A; Abou-Elela D; El-Naidany S; Arafat E; Omar T
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2515-2522. PubMed ID: 31450927
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
Zhuang C; Jiang W; Huang D; Xu L; Yang Q; Zheng L; Wang X; Hu L
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):386-96. PubMed ID: 26669589
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs for the diagnosis of hepatocellular carcinoma.
Peng C; Ye Y; Wang Z; Guan L; Bao S; Li B; Li W
Dig Liver Dis; 2019 May; 51(5):621-631. PubMed ID: 30744930
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
[TBL] [Abstract][Full Text] [Related]
15. Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis.
Liao Q; Han P; Huang Y; Wu Z; Chen Q; Li S; Ye J; Wu X
PLoS One; 2015; 10(6):e0130677. PubMed ID: 26114756
[TBL] [Abstract][Full Text] [Related]
16. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N
Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA signature in hepatocellular carcinoma patients: identification of potential markers.
Elhendawy M; Abdul-Baki EA; Abd-Elsalam S; Hagras MM; Zidan AA; Abdel-Naby AY; Watny M; Elkabash IA; Salem ML; Elshanshoury M; Soliman S; Abdou S
Mol Biol Rep; 2020 Jul; 47(7):4945-4953. PubMed ID: 32430845
[TBL] [Abstract][Full Text] [Related]
19. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
Fouda MS; Omran MM; Tarek G; Hady A Abdel Wahab A
Arab J Gastroenterol; 2021 Mar; 22(1):28-33. PubMed ID: 33268243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
